Frequently Asked Questions

What does TSO3 do?

TSO3 is a leading innovator in low-temperature sterile reprocessing solutions for medical devices, offering sterility and economic efficiency.  TSO3 also partners with developers in creating next-generation medical devices to ensure sterilization for these devices will be viable.

On what stock exchange are TSO3 shares traded, and what is the ticker symbol?

Our ticker symbol is TOS and our common stock is traded on the Toronto Stock Exchange (TSX).

Does TSO3 have a direct stock purchase plan?

We do not currently have a direct stock purchase plan.

Where can I find all of TSO3’s regulatory filings? Where can I download and view quarterly and annual reports?

Quarterly and annual reports, as well as other Canadian regulatory filings, can be accessed on the Corporate Governance page (Documents and Charters tab) of our website or at the SEDAR website—www.sedar.com.

What is TSO3’s fiscal year end?

December 31

When is TSO3’s Annual Shareholders Meeting?

In May 2019, unless otherwise stated

Does TSO3 pay dividends?

We do not expect to declare or pay any cash or other dividends on our common stock, as we intend to reinvest cash flow generated by operations in our business.

Who is the company’s outside legal counsel?

Lavery
1, Place Ville-Marie
Suite 400
Montreal (Quebec) H3B 4M4

Who are the members of the TSO3 Board of Directors?

You can view our Board of Directors by visiting the Corporate Governance page (Board of Directors tab) of our Investor section of the website.

Who are the members of the TSO3 management team?

You can view our management team by visiting the Corporate Governance page (Management tab) of our Investor section of the website.

When did TSO3 become a publicly traded company?

The Shares of our company became publicly traded on the Montreal Exchange (now the TSX Venture Exchange) following the closing of our IPO on August 30, 2001 and then in December 2002,  graduated to Toronto Stock Exchange (TSX).

When is your next earnings release?

We intend to issue a press release that includes the date of our next quarterly earnings call. When the release is issued, it will be posted on the “News & Events” section on our website along with the details for a conference and/or webcast to discuss the results.

How do I contact Investor Relations with a question or request?

You can contact TSO3 Investor Relations via email at: ir@tso3.com

In addition, you can reach Investor Relations by calling Gilmartin Group at 610-368-6505 and Renmark Financial Communications Inc. at 416-644-2020 or 514-939-3989.

Where is TSO3 corporate headquarters?

Québec City, Canada.

TSO3 Corporation, the wholly-owned subsidiary, is located in Myrtle Beach, SC.

Where and when was TSO3 incorporated?

TSO3 was incorporated June 1998 in Québec City, Canada.

TSO3 Corporation, the Company’s wholly-owned subsidiary incorporated in Delaware in 2015, is located in the State of South Carolina, USA and was established to meet US customer requirements.

How can I update my shareholder information for an address or name change?

If your shares are held in a brokerage account, you must notify your broker. If you hold paper stock certificates or a Direct Registration Statement (DRS) in your name, you may send address changes in writing by Mail to our transfer agent: Computershare Investor Services Inc., 1500 University Street Suite 700, Montréal, Québec H3A 3S8; phone 514-982-7888.

Can I replace a lost certificate?

If you hold paper stock certificates in your name, you may send address changes in writing by Mail to our transfer agent: Computershare Investor Services Inc., 1500 University Street Suite 800, Montreal, Quebec H3A 3S8; phone 514-982-7888.

Who are the company’s transfer agents?

Computershare Trust Company of Canada 
1500, University Street
Suite 700
Montréal, Québec H3A 3S8
Tel.: 514-982-7888
Fax: 514-982-7580

Who are the Company’s auditors?

Deloitte LLP
1190, av. des Canadiens-de-Montreal
Suite 500
Montréal, Québec H3B 0M7